BDNF plasma levels in acute stroke

Neuroscience Letters

Volumn 422, Issue 2, 2007, Pages 128-130

  Di Lazzaro, V ^a,b   Profice, P ^a   Pilato, F ^a   Dileone, M ^a   Florio, L ^a   Tonali, P A ^a,b   Angelucci, F ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

BDNF; S100 ; Stroke

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN S100B;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE; VENOUS BLOOD;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN INFARCTION; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBROVASCULAR ACCIDENT; EXTRACELLULAR FLUID; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; S100 PROTEINS; TIME FACTORS; UP-REGULATION;

EID: 34447518590     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.06.001     Document Type: Article

References (14)

1. Belayev L., Busto R., Zhao W., and Ginsberg M.D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739 (1996) 88-96
2. Berger C., Schabitz W.R., Wolf M., Mueller H., Sommer C., and Schwab S. Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp. Neurol. 185 (2004) 305-312
3. Chiaretti A., Piastra M., Polidori G., Di Rocco C., Caresta E., Antonelli A., Amendola T., and Aloe L. Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury. Intens. Care Med. 29 (2003) 1329-1338
4. Kapural M., Krizanac-Bengez Lj., Barnett G., Perl J., Masaryk T., Apollo D., Rasmussen P., Mayberg M.R., and Janigro D. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res. 940 (2002) 102-104
5. Kiprianova I., Sandkühler J., Schwab S., Hoyer S., and Spranger M. BDNF improves long term potentiation and cognitive functions after transient forebrain ischemia in the rat. Exp. Neurol. 159 (1999) 511-519
6. Lindvall O., Ernfors P., Bengzon J., Kokaia Z., Smith M.-L., Siesjö B.K., and Persson H. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 648-652
7. Sakane T., and Pardridge W.M. Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Pharm. Res. 14 (1997) 1085-1091
8. Schäbitz W.R., Berger C., Kollmar R., Seitz M., Tanay E., Kiessling M., Schwab S., and Sommer C. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 35 (2004) 992-997
9. Schäbitz W.R., Schwab S., Spranger M., and Hacke W. BDNF reduces infarct size after permanent MCA occlusion in the rat. J. Cereb. Blood Flow Metab. 17 (1997) 500-506
10. Schäbitz W.R., Sommer C., Zoder W., Kiessling M., Schwaninger M., and Schwab S. Intravenous BDNF reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 31 (2000) 2212-2217
11. Takeda A., Onodera H., Sugimoto A., Kogure K., Obinata M., and Shibahara S. Coordinated expression of messenger RNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the rat hippocampus following transient forebrain ischemia. Neuroscience 55 (1993) 23-31
12. Wu D., and Pardridge W.M. Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 254-259
13. Wunderlich M.T., Ebert A.D., Kratz T., Goertler M., Jost S., and Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 30 (1999) 1190-1195
14. Zhang Y., and Pardridge W.M. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin. Brain Res. 889 (2001) 49-56